BBN SOFTWARE PRODUCTS FORGES STRATEGIC ALLIANCE WITH BELMONT RESEARCH; Will Give Health Industry Companies More Innovative Software To Support New Drug Development.CAMBRIDGE, Mass.--(BUSINESS WIRE)--November 11, 1994--BBN Software Products Corporation, a subsidiary of Bolt Beranek and Newman Inc. (NYSE NYSE See: New York Stock Exchange :BBN (BBN Technologies, Cambridge, MA, www.bbn.com) A consulting firm that participated in the development of some of the most extensive networks in the world, including ARPANET, which evolved into the Internet. It was founded in 1948 as a consulting service in acoustics by Dr. ), today announced it has formed a strategic alliance with Belmont Research, Inc., located in Cambridge, Massachusetts This article is about the city of Cambridge in Massachusetts. For the English university town, see Cambridge, England. For other places, see Cambridge (disambiguation). Cambridge, Massachusetts is a city in the Greater Boston area of Massachusetts, United States. . BBN Software Products also announced it has invested in the software development company. Today's announcement builds on an existing -- and highly successful -- five-year relationship between the two companies. BBN has collaborated with Belmont Research on software development work and consulting associated with BBN's ClintrialTM and ClinTRACETM clinical research software products. Clintrial is the number one clinical trials data management software package worldwide. More drugs have been approved with this software than any other. ClinTRACE is used to track and report adverse events. The alliance between the two companies will include joint technology development, consulting and collaboration on innovative new software products. As part of the alliance, John Kish, BBN Software Products' president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , will join Belmont Research's board of directors. "Our investment in Belmont Research highlights the continued growth of BBN's commitment to the health industry. By more tightly collaborating with this prestigious software developer, we deepen deep·en tr. & intr.v. deep·ened, deep·en·ing, deep·ens To make or become deep or deeper. deepen Verb to make or become deeper or more intense Verb 1. our resources to bring creative solutions to health companies worldwide," Kish said. Founded in 1990, Belmont Research is dedicated to identifying and developing promising new software technologies for research applications. The Cambridge, Massachusetts-based organization has expertise in a variety of areas relating to relating to relate prep → concernant relating to relate prep → bezüglich +gen, mit Bezug auf +acc new drug development, including bioinformatics Using computers in biological research to analyze or predict the composition of molecules (nucleic acids, proteins, etc.) and model biologic systems. Bioinformatics is most prominent in the Human Genome Project, which has recorded the three billion chemical base pairs that make up the , pre-clinical and clinical research, and drug safety monitoring Safety Monitoring of a clinical trial is conducted by an independent physician with relevant expertise. This is accomplished by review of adverse event, immediately after they occur, with timely follow-up through resolution. . Chan Russell, president and founder of Belmont Research, believes his company's new alliance will help support BBN Software Products' objective of aggressively meeting the information-handling needs of drug research and development. "We are delighted BBN Software Products has invested in our company and proud to be associated with the recognized leader in software for drug research and development. The strengthened partnership between our two companies will accelerate the development and deployment of new health industry solutions," Russell said. In October, Belmont Research was one of a select group of companies awarded funding for ground-breaking research and development under the National Institute of Standards and Technology's Advanced Technology Program (ATP ATP: see adenosine triphosphate. ATP in full adenosine triphosphate Organic compound, substrate in many enzyme-catalyzed reactions (see catalysis) in the cells of animals, plants, and microorganisms. ). Belmont Research will work on a multi-year ATP program to develop critical information infrastructure technologies for the healthcare industry. "Making data make sense" is the goal of BBN Software Products Corporation. Major companies worldwide use BBN's software to turn their data into valuable information to save time, improve product quality, and comply with regulatory requirements Regulatory requirements are part of the process of drug discovery and drug development. Regulatory requirements describe what is necessary for a new drug to be approved for marketing in any particular country. . BBN's products include RS/SeriesTM software, CornerstoneTM software, Clintrial software, ClinTRACE software and BBN/ProbeTM software. Headquartered in Cambridge, Mass., BBN Software Products Corp. is a subsidiary of Bolt Beranek and Newman Inc. For the fiscal year ending June 30, 1994, Bolt Beranek and Newman Inc. reported sales of $196 million. -0- BBN/Probe, ClinTRACE, Clintrial, Cornerstone cornerstone Ceremonial building block, dated or otherwise inscribed, usually placed in an outer wall of a building to commemorate its dedication. Often the stone is hollowed out to contain newspapers, photographs, or other documents reflecting current customs, with a view to and RS/Series are trademarks of Bolt Beranek and Newman Inc.
CONTACT: Jeffrey H. Palmer Jeffrey Mayersohn
BBN Software Products Corp. Bolt Beranek and Newman Inc.
(Trade Contact) (Investor Contact)
617/873-3953 617/873-3596
Laura Desmarais William Blackwell
Beaupre & Co. Public Relations Belmont Research
603/436-6690 617/868-6878
|
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion